SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 11,526.01 |
Enterprise Value ($M) | 11,638.47 |
Book Value ($M) | 2,138.65 |
Book Value / Share | 13.46 |
Price / Book | 5.39 |
NCAV ($M) | 51.20 |
NCAV / Share | 0.32 |
Price / NCAV | 225.12 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.06 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.26 |
Current Ratio | 4.56 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 648.57 |
Assets | 2,736.02 |
Liabilities | 597.37 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1,159.06 |
Operating Income | 207.41 |
Net Income | 168.10 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 298.98 |
Cash from Investing | -203.03 |
Cash from Financing | -122.40 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Price T Rowe Associates Inc /md/ | 5.90 | ||
13G/A | BlackRock, Inc. | 8.70 | 0.00 | |
13G/A | Vanguard Group Inc | 11.53 | 0.16 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
445,446 | 2,126,181 | 20.95 | |
313,077 | 1,005,272 | 31.14 | |
243,403 | 1,124,845 | 21.64 | |
87,087 | 637,425 | 13.66 | |
92,882 | 481,524 | 19.29 | |
(click for more detail) |
Similar Companies | |
---|---|
SYRE – Spyre Therapeutics, Inc. | SYRS – Syros Pharmaceuticals, Inc. |
TARS – Tarsus Pharmaceuticals, Inc. | TERN – Terns Pharmaceuticals, Inc. |
TLRY – Tilray Brands, Inc. |
Financial data and stock pages provided by
Fintel.io